June 2021 - Discovery of liquid biopsy-based biomarker for uveal melanoma

Montreal researcher wins award for developing world’s first non-invasive blood screening test for early detection of eye cancer. Ms Prisca Bustamante — a PhD candidate researcher working at the Research Institute of the McGill University Health Centre under Dr. Julia Burnier in the Department of Oncology and Pathology at McGill University — is being recognized for developing the first-ever liquid biopsy for uveal melanoma, the most common intra-ocular tumour found in adults. Though rare, the disease can be lethal in a small percentage of Canadians who develop it each year due to the lack of early detection methods. You can read more about it HERE. 

You can read the published research paper HERE